Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy.
about
Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptorsBehavioral Abnormality Induced by Enhanced Hypothalamo-Pituitary-Adrenocortical Axis Activity under Dietary Zinc Deficiency and Its Usefulness as a ModelIncreases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acidsBerberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral CortexAcacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in ratsAdenosine receptors as drug targets--what are the challenges?The relationship between the apparent diffusion coefficient measured by magnetic resonance imaging, anoxic depolarization, and glutamate efflux during experimental cerebral ischemia.High extracellular glutamate and neuronal death in neurological disorders. Cause, contribution or consequence?Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.Self-induced accumulation of glutamate in striatal astrocytes and basal ganglia excitotoxicity.Mechanical strain injury increases intracellular sodium and reverses Na+/Ca2+ exchange in cortical astrocytes.Resveratrol neuroprotection in stroke and traumatic CNS injury.General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage.Long-term potentiation in the dentate gyrus of the anaesthetized rat is accompanied by an increase in extracellular glutamate: real-time measurements using a novel dialysis electrodeMyricetin inhibits the release of glutamate in rat cerebrocortical nerve terminals.Impaired cognitive function and mental performance in mild dehydration.AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs.Curcumin inhibits glutamate release from rat prefrontal nerve endings by affecting vesicle mobilization.Acute decrease in net glutamate uptake during energy deprivation.Sigma receptors [σRs]: biology in normal and diseased statesMolecular physiology of preconditioning-induced brain tolerance to ischemia.Echinacoside Inhibits Glutamate Release by Suppressing Voltage-Dependent Ca(2+) Entry and Protein Kinase C in Rat Cerebrocortical Nerve TerminalsRegulation of cerebral vasculature in normal and ischemic brainLocal glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injuryCalpain and the glutamatergic synapseGestational restraint stress and the developing dopaminergic system: an overview.Comparisons of mass spectrometry compatible surfactants for global analysis of the mammalian brain proteomeNeuroprotective strategies: voltage-gated Na+-channel down-modulation versus presynaptic glutamate release inhibition.Neurotoxicity mediated by aberrant patterns of synaptic activity between rat hippocampal neurons in culture.Atorvastatin Prevents Glutamate Uptake Reduction Induced by Quinolinic Acid Via MAPKs Signaling.Expression of cell cycle proteins in cortical neurons-Correlation with glutamate-induced neurotoxicity.Xanthohumol-induced presynaptic reduction of glutamate release in the rat hippocampus.Insight into glutamate excitotoxicity from synaptic zinc homeostasisDeletion of presynaptic adenosine A1 receptors impairs the recovery of synaptic transmission after hypoxia.Delirium-associated disulfiram and ethanol interactions.Mystixin-7 Peptide Protects Ionotropic Glutamatergic Mechanisms against Glutamate-Induced Excitotoxicity In Vitro.Substantia nigra osmoregulation: taurine and ATP involvement.Imaging anoxic depolarization during ischemia-like conditions in the mouse hemi-brain slice.Evidence that REM sleep is controlled by the activation of brain stem pedunculopontine tegmental kainate receptor.A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures.
P2860
Q24796326-DECAE521-3406-45B6-864F-ABFB520366E8Q26738739-854A3D3B-EFB1-4032-BEEB-0F9D2BED56F8Q28344761-9F448EE1-BB82-41A0-A116-31101F2DD22FQ28533983-EA82851D-16D4-48E3-934B-FCE6788328A3Q28539687-1C8849A3-0952-42CC-AB88-573E36ADEA7BQ29346491-F0A4EDC6-F69E-4C4F-AFAA-4FD451D19ADEQ33179383-82AF183A-4735-4E65-8066-16E20EEA0DF5Q33834183-62798BD2-0D95-4A9A-B65B-F4750F57DDC8Q34213029-1D5F4D73-FD1D-40AB-899E-AA0E9D4649B4Q34310129-894B4A3F-65DE-48CB-B16F-CF6CB969AACBQ34374927-543F91B9-6631-4DBB-91BB-400C1028D2BCQ34489690-F0DD53AB-597F-42BC-B070-9C6B6D3AC417Q34660713-5377C0A7-8EBA-4DE4-8B73-B043CAB6E30AQ35213510-74AAA0C8-ACCF-4CED-838B-DE91A9DAAA4BQ35541437-97815160-F285-45B9-A3F0-E131ACFA4115Q35610075-8BC3E956-5AEE-4C3C-BF8C-55D0C701F188Q35809357-F3B0FEA0-FB8D-40CB-B991-0C9BEB687400Q36197383-FCA1A726-5C45-4EC6-97B4-3AF6AF3BD220Q36985138-8E75A3F7-6752-4CD0-BB74-4FC942D266A2Q37000551-2FAB9824-6D2B-4714-BB03-8EE0F4D5BC17Q37056974-E793F174-0434-40E5-BE13-C07968DBCCACQ37134337-4081BF83-6E13-4B85-863B-56BAC32771EDQ37186979-64728E54-41EE-4AF8-B5C0-95DB2F9F5156Q37347604-86A0E9C2-805A-468C-B78A-1F2DB48BA306Q37502232-EE359E22-3E7F-48E1-AC83-1A42422247B4Q37973031-4158BF7D-3CB5-46BD-9686-1533E8A922B4Q38512252-9B2F4480-DA83-4421-B7CD-3D47006B451CQ39262747-DE60977A-5851-4F97-97D9-7105EF30F9EEQ39479989-F4C9AC49-7649-477C-9060-549CEF30BF00Q39846471-FFED19E0-BA97-49BF-B1B1-02CCA23E29D0Q39867433-177F855C-E198-41F8-8FD4-913E9FA3629FQ40212486-02493216-171A-4A3F-A609-0BE661703B4BQ41811368-E9691AA6-1198-440D-9357-16E15BEE9D11Q41826276-3CD8FE74-3117-409F-B5FA-83113F9AE91CQ42008157-D34BFBB7-6B9E-4247-9D97-9370CD3A5A79Q42138978-9BD4A209-CA2C-43F4-98A5-B8F77CFA71C6Q42506648-9BC32EC1-C369-4406-860A-31C943E8918EQ43518034-00471CB0-E223-4C10-9560-54307CE6469DQ43945319-1CC3E5A4-029E-4892-8C3F-60B228601113Q44079756-7F1B2CAC-64D4-4CE0-862F-043784E4ACFC
P2860
Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Altered glutamatergic transmis ...... o excessive synaptic efficacy.
@en
type
label
Altered glutamatergic transmis ...... o excessive synaptic efficacy.
@en
prefLabel
Altered glutamatergic transmis ...... o excessive synaptic efficacy.
@en
P1476
Altered glutamatergic transmis ...... o excessive synaptic efficacy.
@en
P2093
Obrenovitch TP
P356
10.1016/S0301-0082(96)00049-4
P577
1997-01-01T00:00:00Z